Viruses in Glioblastoma: an Update on Evidence and Clinical Trials

Overview

Journal BJC Rep

Publisher Nature Portfolio

Date 2024 Nov 8

PMID 39516641

Authors

Bavani Gunasegaran

Caroline L Ashley

Felix Marsh-Wakefield

Gilles J Guillemin

Benjamin Heng

Affiliations

Soon will be listed here.

Abstract

Background: Glioblastoma (GB) is a lethal and aggressive brain tumour. While molecular characteristics of GB is studied extensively, the aetiology of GB remains uncertain. The interest in exploring viruses as a potential contributor to the development of GB stems from the notion that viruses are known to play a key role in pathogenesis of other human cancers such as cervical cancer. Nevertheless, the role of viruses in GB remains controversial.

Methods: This review delves into the current body of knowledge surrounding the presence of viruses in GB as well as provide updates on clinical trials examining the potential inclusion of antiviral therapies as part of the standard of care protocol.

Conclusions: The review summarises current evidences and important gaps in our knowledge related to the presence of viruses in GB.

Citing Articles

Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology.

Horta M, Soares P, Leite Pereira C, Lima R Pharmaceutics. 2025; 17(2).

PMID: 40006509 PMC: 11859630. DOI: 10.3390/pharmaceutics17020142.

Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Nazarenko A, Shkirdova A, Orlova E, Biryukova Y, Vorovitch M, Kolyasnikova N Int J Mol Sci. 2024; 25(23).

PMID: 39684289 PMC: 11640982. DOI: 10.3390/ijms252312578.

References

Mitchell D, Xie W, Schmittling R, Learn C, Friedman A, McLendon R . Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol. 2007; 10(1):10-8. PMC: 2600830. DOI: 10.1215/15228517-2007-035. View

Alibek K, Baiken Y, Kakpenova A, Mussabekova A, Zhussupbekova S, Akan M . Implication of human herpesviruses in oncogenesis through immune evasion and supression. Infect Agent Cancer. 2014; 9(1):3. PMC: 3904197. DOI: 10.1186/1750-9378-9-3. View

Del Vecchio C, Calistri A, Parolin C, Mucignat-Caretta C . Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma. Cancers (Basel). 2019; 11(3). PMC: 6468594. DOI: 10.3390/cancers11030417. View

Strong M, Blanchard 4th E, Lin Z, Morris C, Baddoo M, Taylor C . A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association. Acta Neuropathol Commun. 2016; 4(1):71. PMC: 4940872. DOI: 10.1186/s40478-016-0338-z. View

Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M . WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?. Acta Neuropathol. 2007; 114(2):111-9. DOI: 10.1007/s00401-007-0231-8. View

Nair S, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J . Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res. 2014; 20(10):2684-94. PMC: 4059212. DOI: 10.1158/1078-0432.CCR-13-3268. View

Verdugo E, Puerto I, Medina M . An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Commun (Lond). 2022; 42(11):1083-1111. PMC: 9648390. DOI: 10.1002/cac2.12361. View

Sehrawat S, Kumar D, Rouse B . Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?. Front Cell Infect Microbiol. 2018; 8:177. PMC: 5981231. DOI: 10.3389/fcimb.2018.00177. View

Huang H, Reis R, Yonekawa Y, Lopes J, Kleihues P, Ohgaki H . Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol. 1999; 9(1):33-42. PMC: 8098629. DOI: 10.1111/j.1750-3639.1999.tb00207.x. View

10.

Dorries K, Sbiera S, Drews K, Arendt G, Eggers C, Dorries R . Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals. J Neurovirol. 2003; 9 Suppl 1:81-7. DOI: 10.1080/13550280390195379. View

11.

PANDE H, Forman S, Tanamachi B, Li C, Zaia J, Greenberg P . Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol. 1994; 43(1):103-10. DOI: 10.1002/jmv.1890430119. View

12.

Zavala-Vega S, Castro-Escarpulli G, Hernandez-Santos H, Salinas-Lara C, Palma I, Mejia-Arangure J . An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol Res Pract. 2017; 213(3):271-276. DOI: 10.1016/j.prp.2016.12.006. View

13.

Soderberg-Naucler C, Rahbar A, Stragliotto G . Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med. 2013; 369(10):985-6. DOI: 10.1056/NEJMc1302145. View

14.

Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan M, Hassannia T, Rahimi H, Miri R . Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). Iran J Basic Med Sci. 2014; 16(3):179-95. PMC: 3881257. View

15.

Marelli G, Howells A, Lemoine N, Wang Y . Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer. Front Immunol. 2018; 9:866. PMC: 5932159. DOI: 10.3389/fimmu.2018.00866. View

16.

Mittal S, Klinger N, Michelhaugh S, Barger G, Pannullo S, Juhasz C . Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg. 2017; 128(2):414-421. PMC: 6836465. DOI: 10.3171/2016.9.JNS16452. View

17.

Hishii M, Nitta T, Ishida H, Ebato M, Kurosu A, Yagita H . Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery. 1995; 37(6):1160-6; discussion 1166-7. DOI: 10.1227/00006123-199512000-00016. View

18.

Parney I, Chang L, Petruk K . Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery. 2000; 46(5):1169-77; discussion 1177-8. DOI: 10.1097/00006123-200005000-00030. View

19.

Kramer M, Cook W, Roth F, Zhu J, Holman H, Knipe D . Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression. J Virol. 2003; 77(17):9533-41. PMC: 187408. DOI: 10.1128/jvi.77.17.9533-9541.2003. View

20.

Virgin H, Wherry E, Ahmed R . Redefining chronic viral infection. Cell. 2009; 138(1):30-50. DOI: 10.1016/j.cell.2009.06.036. View